Amgen (English Wikipedia)

BUKSA Strategic Conference Services (2021). "Virtual Series Sponsor Profile: Amgen". Alberta Kidney Days Virtual Series. Archived from the original on 2022-08-02. Retrieved 2022-08-02.

amazonaws.com

uw-s3-cdn.s3.us-west-2.amazonaws.com

"Honor Roll of Donors" (PDF). University of Washington; Amazon Web Services. 2020. Archived (PDF) from the original on 2022-06-10. Retrieved 2022-08-05.

amgen.com

Amgen press office. Biovitrum Closes Product Acquisition Deal with Amgen Archived July 3, 2012, at the Wayback Machine
"Amgen's ESG Datasheet for 2020Q4" (PDF). Alt URL
"Amgen's Sustainability Report for 2020Q4" (PDF). Archived from the original (PDF) on July 17, 2021. Alt URL
Higgins, Connie (2020-04-28). "Amgen Foundation commits $2M to Ventura and Los Angeles Counties COVID-19 response" (PDF). Amgen. Archived (PDF) from the original on 2022-07-06. Retrieved 2022-08-04.

wwwext.amgen.com

"About Amgen Fact Sheet". amgen.com. Retrieved 9 March 2020.

amgenhistory.com

Amgen History official site page accessed January 2, 2016

amgenpipeline.com

"Amgen Pipeline". Amgen Pipeline. Retrieved 16 August 2022.

archive.today

Walker, Joseph (4 August 2022). "Amgen to Buy ChemoCentryx for $3.7 Billion". The Wall Street Journal. Archived from the original on 4 August 2022.
"Donor Listing". University of Toronto. Archived from the original on 2021-04-23. Retrieved 2022-08-06.
"Sponsors". Mentoring in IBD. 2022. Archived from the original on 2022-04-19. Retrieved 2022-08-02.
"Donor List". Providence Health Care. Archived from the original on 2022-02-08. Retrieved 2022-08-05.
"Corporate Support". American Society of Hematology. 2022. Archived from the original on 2022-06-10. Retrieved 2022-08-02.
"Partners". Arthritis Society. 2022. Archived from the original on 2022-05-14. Retrieved 2022-08-02.
"2019 Donors to the CSHP Foundation by Giving Level". Canadian Society of Hospital Pharmacists. Archived from the original on 2022-04-19. Retrieved 2022-08-04.
"Our Partners". CSN/SCN. 2022. Archived from the original on 2022-01-08. Retrieved 2022-08-02.
"Corporate Liaison Board". Endocrine Society. 2022. Archived from the original on 2022-06-10. Retrieved 2022-08-02.
"List of Members". Alliance for a Stronger FDA. 2022-03-04. Archived from the original on 2022-07-08. Retrieved 2022-08-02.
"Active Members". The Business Council. 2022. Archived from the original on 2022-07-13. Retrieved 2022-07-02.
"Members". Health Products Stewardship Association. 2022. Archived from the original on 2022-04-27. Retrieved 2022-08-04.
"Our Sponsors". Life Sciences British Columbia. 2021-01-06. Archived from the original on 2022-04-25. Retrieved 2022-08-04.
"Member Organizations". Research!America. 2022. Archived from the original on 2022-04-06. Retrieved 2022-08-05.
"Our Sponsors and Prizes". BC Pharmacy Association. 2022. Archived from the original on 2022-05-23. Retrieved 2022-08-02.
"Current Sponsors". Canadian Association of Gastroenterology. 2022. Archived from the original on 2022-04-21. Retrieved 2022-08-02.
"Corporate Sponsors - CRA". Canadian Rheumatology Association. 2017-11-18. Archived from the original on 2022-03-01. Retrieved 2022-08-02.
"Home". CUA Meeting 2022. 2021. Archived from the original on 2022-05-16. Retrieved 2022-08-02.

arthritis.ca

"Partners". Arthritis Society. 2022. Archived from the original on 2022-05-14. Retrieved 2022-08-02.

ascopost.com

"FDA Approves Blinatumomab to Treat Rare Form of Acute Lymphoblastic Leukemia". The ASCO Post. 15 December 2014. Retrieved 11 August 2022.
ASCO Post Staff (June 25, 2021). "FDA Approves Sotorasib for KRAS G12C–Mutated NSCLC". ASCO Post. Retrieved March 4, 2022.
Helwick, Caroline (1 Feb 2021). "Phase II CodeBreak 100 Validates Early Benefit for KRAS Inhibitor in NSCLC". The ASCO Post. Retrieved 16 August 2022.
ASCO Post Staff (June 25, 2021). "FDA Approves Sotorasib for KRAS G12C–Mutated NSCLC". ascopost.com. Retrieved March 4, 2022.

bcpharmacy.ca

"Our Sponsors and Prizes". BC Pharmacy Association. 2022. Archived from the original on 2022-05-23. Retrieved 2022-08-02.

bcrenal.ca

"Compassion in kidney care: from patients to providers" (PDF). BC Renal Agency. 2013. Archived (PDF) from the original on 2022-01-08. Retrieved 2022-08-02.

biopharma-reporter.com

Brennan, Zachary (21 November 2014). "Amgen launches $200m biomanufacturing facility in Singapore". BioPharma-Reporter. Retrieved 11 August 2022.

biopharmadive.com

Bell, Jacob (8 February 2017). "Amgen secures FDA approval for hormone drug". BioPharma Dive. Retrieved 11 August 2022.
Pagliarulo, Ned (11 January 2022). "Amgen partners with Arrakis to develop drugs aimed at RNA". BioPharma Dive. Retrieved 23 September 2022.
Gardner, Jonathan (23 Nov 2020). "Amgen cuts Cytokinetics loose after heart drug disappointment". BioPharma Dive. Retrieved 16 August 2022.

biospace.com

"Amgen to Acquire Otezla® for $13.4 Billion in Cash, or Approximately $11.2 Billion Net of Anticipated Future Cash Tax Benefits". 26 August 2019.
"Amgen to Acquire Five Prime Therapeutics for $1.9 Billion in Cash". 4 March 2021.
"In Second Acquisition this Month, Amgen Buys Rodeo for $721 Million". 31 March 2021.
"How Amgen Acquired Five Prime for $1.9 Billion, Beating Out a Dozen Others". BioSpace. 2021-03-19. Retrieved 2024-09-11.
Shasteen, Hayley (3 February 2022). "Amgen and Plexium Ink $500M Targeted Protein Degradation Therapies Pact". BioSpace. Retrieved 23 September 2022.

biotech.ca

"Member Listings". BIOTECanada. 2021-12-23. Archived from the original on 2022-08-02. Retrieved 2022-08-02.

bipartisanpolicy.org

Grumet, Jason (2016). "Dialogue Issue III: The Annual Report Issue 2015-2016" (PDF). Bipartisan Policy Center. Archived (PDF) from the original on 2022-07-07. Retrieved 2022-08-02.

bloomberg.com

Mutua, David Caleb (29 March 2022). "Amgen Mulls More Green Bonds After 'Robust Interest' in Debut". www.bloomberg.com. Retrieved 23 September 2022.

books.google.com

Ronald Vogel. Pharmaceutical Economics and Public Policy. CRC Press, 2007. ISBN 9781439801345. P. 208
Kim, Rachel (2019). Economics and management in the biopharmaceutical industry in the USA : evolution and strategic change. London: Routledge. pp. 2002–2003. ISBN 9781351012690. Retrieved 10 August 2022.

businesscouncil.com

"Active Members". The Business Council. 2022. Archived from the original on 2022-07-13. Retrieved 2022-07-02.

cag-acg.org

"Current Sponsors". Canadian Association of Gastroenterology. 2022. Archived from the original on 2022-04-21. Retrieved 2022-08-02.

campustechnology.com

Kelly, Rhea (24 January 2020). "Amgen and Harvard Launch Free Online Science Ed Platform -- Campus Technology". Campus Technology. Retrieved 11 August 2022.

cancernetwork.com

Audrey Sternberg (January 20, 2022). "Sotorasib Earns Approval in Japan for KRAS G12C+ NSCLC". cancernetwork.com. Retrieved March 4, 2022.

cancerresearch.org

Tontonoz, Matthew. "T-VEC is First FDA-Approved Oncolytic Virus Therapy". Cancer Research Institute. Retrieved 11 August 2022.

cansolveckd.ca

"Funding Partners". Can-SOLVE CKD Network. 2022. Archived from the original on 2022-08-02. Retrieved 2022-08-02.

car.ca

"Corporate Partners". CAR - Canadian Association of Radiologists. 2022. Archived from the original on 2022-07-19. Retrieved 2022-08-02.

ccrm.ca

"Industry Network". CCRM. 2019-04-10. Archived from the original on 2022-08-02. Retrieved 2022-08-02.

cdcfoundation.org

"CDC Foundation Active Programs October 1, 2020 – September 30, 2021". CDC Foundation. 2021-12-09. Archived from the original on 2022-01-15. Retrieved 2022-08-06.
"CDC Foundation Active Programs". CDC Foundation. 2021-12-09. Archived from the original on 2022-01-15. Retrieved 2022-08-02.

centerforbiosimilars.com

"FDA Approves Amgen's Trastuzumab Biosimilar, Kanjinti". The Center For Biosimilars. 13 June 2019. Retrieved 11 August 2022.
Hagen, Tony (4 February 2021). "Amgen Profits Get a Ride on Biosimilar Growth". The Center For Biosimilars. Retrieved 12 July 2022.

cfr.org

"Corporate Members". Council on Foreign Relations. Retrieved 2022-08-02.

cheddar.com

Vuocolo, Alex (23 June 2020). "Khan Academy Founder Says $3M Grant Will Help Tackle Inequities in Virtual Education". Cheddar News. Retrieved 11 August 2022.

clinicaloncology.com

"FDA Approves Riabni, Third Biosimilar to Rituxan". Clinical Oncology News. 18 December 2020. Retrieved 20 September 2022.

cnbc.com

Stevens, Pippa (24 August 2020). "Salesforce, Amgen and Honeywell added to Dow in major shake-up to the average". CNBC. Retrieved 11 August 2022.

colorectalcancercanada.com

"Our Partnerships". Colorectal Cancer Canada. 2021. Archived from the original on 2022-05-16. Retrieved 2022-08-02.

cshp-scph.ca

"2019 Donors to the CSHP Foundation by Giving Level". Canadian Society of Hospital Pharmacists. Archived from the original on 2022-04-19. Retrieved 2022-08-04.

csnscn.ca

"Our Partners". CSN/SCN. 2022. Archived from the original on 2022-01-08. Retrieved 2022-08-02.

cuameeting.org

"Home". CUA Meeting 2022. 2021. Archived from the original on 2022-05-16. Retrieved 2022-08-02.

doi.org

Bendall, Linda J.; Bradstock, Kenneth F. (August 2014). "G-CSF: From granulopoietic stimulant to bone marrow stem cell mobilizing agent". Cytokine & Growth Factor Reviews. 25 (4): 355–367. doi:10.1016/j.cytogfr.2014.07.011. PMID 25131807.
Przepiorka, Donna; Ko, Chia-Wen; Deisseroth, Albert; Yancey, Carolyn L.; Candau-Chacon, Reyes; Chiu, Haw-Jyh; Gehrke, Brenda J.; Gomez-Broughton, Candace; Kane, Robert C.; Kirshner, Susan; Mehrotra, Nitin; Ricks, Tiffany K.; Schmiel, Deborah; Song, Pengfei; Zhao, Ping; Zhou, Qing; Farrell, Ann T.; Pazdur, Richard (15 September 2015). "FDA Approval: Blinatumomab". Clinical Cancer Research. 21 (18): 4035–4039. doi:10.1158/1078-0432.CCR-15-0612. ISSN 1557-3265. PMID 26374073. S2CID 207687724. Retrieved 11 August 2022.
Giusti, Ruthann M.; Shastri, Kaushikkumar A.; Cohen, Martin H.; Keegan, Patricia; Pazdur, Richard (May 2007). "FDA drug approval summary: panitumumab (Vectibix)". The Oncologist. 12 (5): 577–583. doi:10.1634/theoncologist.12-5-577. ISSN 1083-7159. PMID 17522246. S2CID 9376408. Retrieved 10 August 2022.
Hemmelgarn, Brenda R.; Clement, Fiona; Manns, Braden J.; Klarenbach, Scott; James, Matthew T.; Ravani, Pietro; Pannu, Neesh; Ahmed, Sofia B.; MacRae, Jennifer; Scott-Douglas, Nairne; Jindal, Kailash (2009-10-19). "Overview of the Alberta Kidney Disease Network". BMC Nephrology. 10 (1): 30. doi:10.1186/1471-2369-10-30. ISSN 1471-2369. PMC 2770500. PMID 19840369.

efpia.eu

"Membership". European Federation of Pharmaceutical Industries and Associations. 2022. Archived from the original on 2022-07-01. Retrieved 2022-08-02.

endocrine.org

"Corporate Liaison Board". Endocrine Society. 2022. Archived from the original on 2022-06-10. Retrieved 2022-08-02.

escardio.org

"Why sponsor the EURObservational Registry Programme". European Society of Cardiology. 2022. Archived from the original on 2022-06-15. Retrieved 2022-08-03.

exerica.com

analytics.exerica.com

"Amgen's ESG Datasheet for 2020Q4" (PDF). Alt URL
"Amgen's Sustainability Report for 2020Q4" (PDF). Archived from the original (PDF) on July 17, 2021. Alt URL

fda.gov

accessdata.fda.gov

"Drugs@FDA: FDA Approved Drug Products".
"Drugs@FDA: FDA Approved Drug Products".
"Drugs@FDA: FDA Approved Drug Products".
"www.accessdata.fda.gov" (PDF).
"Drug Approval Package: Sensipar (Cinacalcet HCI) NDA #021688". U.S. Food and Drug Administration. Retrieved 10 August 2022.

fda.gov

"FDA approves Xgeva to help prevent cancer-related bone injury". Food and Drug Administration.
Food and Drug Administration December 3, 2014 FDA Press release: Blinatumomab

fdocuments.in

"The 8th Princess Margaret Hospital Conference: Developments in Cancer Management". FDocuments India. 2020-07-17. Archived from the original on 2022-06-20. Retrieved 2022-08-05.

fiercebiotech.com

"Amgen bets up to $1.7B on Xencor's antibody technology". FierceBiotech. 16 September 2015.
Taylor, Phil (9 January 2019). "Amgen gets first OK for Evenity in Japan as FDA panel looms". Fierce Biotech. Retrieved 11 August 2022.
Idrus, Amirah Al (1 June 2021). "Amgen reunites with longtime partner Kyowa Kirin in $400M dermatitis deal". Fierce Biotech. Retrieved 20 September 2022.
Taylor, Nick Paul (7 October 2021). "Meet Neumora, Arch's $500M, Amgen-partnered play for the targeted future of neuroscience R&D". Fierce Biotech. Retrieved 20 September 2022.
Armstrong, Annalee (6 January 2022). "Amgen chooses Generate in $1.9B biobucks deal to churn out up to 10 multispecific drugs". Fierce Biotech. Retrieved 23 September 2022.
Armstrong, Annalee (11 January 2022). "JPM 2022: Amgen teams up with Arrakis to destroy disease-causing RNA in $75M research deal". Fierce Biotech. Retrieved 23 September 2022.
LaHucik, Kyle (3 February 2022). "Amgen enters hot protein degradation field with $500M biobucks deal with Plexium". Fierce Biotech. Retrieved 23 September 2022.
Adams, Ben (4 March 2021). "Prime time for Five Prime as Amgen snaps up this once-moribund biotech for $1.9B and its phoenix-from-the-flames cancer asset". Fierce Biotech. Retrieved 23 September 2022.
Idrus, Amirah Al (30 March 2021). "Amgen saddles up with Rodeo for a $55M trek into regenerative medicine". Fierce Biotech. Retrieved 23 September 2022.
Taylor, Nick Paul (8 December 2020). "Amgen plans 2020 filing for FDA approval of KRAS drug sotorasib". Fierce Biotech. Retrieved 16 August 2022.

fiercepharma.com

Becker, Zoey (27 June 2022). "Amgen partners with Fosun to bring Otezla, Parsabiv to patients in China". Fierce Pharma.
Staton, Tracy (23 September 2016). "Amgen's Humira biosim, Amjevita, passes FDA milestone on long road to market". Fierce Pharma. Retrieved 11 August 2022.
Liu, Angus (10 April 2019). "Amgen bone drug Evenity finally wins its FDA green light, but there's a catch". Fierce Pharma. Retrieved 11 August 2022.
Liu, Angus (23 January 2020). "Amgen wades deeper into Asia with full control of an Astellas Japanese JV". Fierce Pharma. Retrieved 11 August 2022.
Blankenship, Kyle (17 September 2020). "Eli Lilly, Amgen join forces to scale production of COVID-19 antibody cocktails". Fierce Pharma. Retrieved 11 August 2022.
Dunleavy, Kevin (20 December 2021). "Amgen, AstraZeneca score FDA nod for blockbuster hopeful asthma drug Tezspire". Fierce Pharma. Retrieved 20 September 2022.
Blankenship, Kyle (27 July 2020). "The top 20 drugs by global sales in 2019". Fierce Pharma. Retrieved 12 July 2022.
Liu, Angus (3 August 2020). "AbbVie, Amgen and Takeda test anti-inflammatory drugs in joint COVID-19 study". Fierce Pharma.

flippingbook.com

online.flippingbook.com

"St. Michael's Foundation 2020/21 Annual Report". FlippingBook. 2021. Archived from the original on 2022-08-05. Retrieved 2022-08-05.

fmwc.ca

"AGM 2010: The Many Faces of Medical Women" (PDF). Federation of Medical Women in Canada. 2010. Archived (PDF) from the original on 2022-03-06. Retrieved 2022-08-03.

fnih.org

2020-annual-report.fnih.org

"2020 Donors". FNIH 2020 Annual Report. Archived from the original on 2022-03-16. Retrieved 2022-08-03.

forbes.com

"A Biotech Wonder Grows Up". Forbes. 3 Sep 2001. Retrieved 10 August 2022.
Husten, Larry. "Amgen Pleads Guilty To Misbranding Anemia Drug Aranesp". Forbes. Retrieved 2 February 2013.

fortune.com

"Fortune 500 company by revenue 2018 cial". www.fortune.com. Archived from the original on 2020-03-29. Retrieved 2019-03-18.

foxbusiness.com

Manfredi, Lucas (18 January 2021). "CEOs are driving an initiative to hire, train 1M Black workers over next 10 years". FOXBusiness. Retrieved 11 August 2022.

gabionline.net

"FDA approves bevacizumab biosimilar Mvasi". GaBI Online. 22 September 2017. Retrieved 11 August 2022.

genengnews.com

Philippidis, Alex (1 November 2019). "Amgen Expands China Presence, Cancer R&D with $2.7B BeiGene Collaboration". GEN - Genetic Engineering and Biotechnology News. Retrieved 11 August 2022.
"GEN - News Highlights:Amgen Halts Rilotumumab Trials in Advanced Gastric Cancer". GEN. 24 November 2014.
"GEN - News Highlights:Brodalumab's No Turkey in Phase III: Amgen and AstraZeneca". GEN.
Writer, GEN Staff (25 April 2012). "Amgen Ponies Up $700M for Turkey's Mustafa Nevzat". GEN - Genetic Engineering and Biotechnology News. Retrieved 10 August 2022.
"Amgen to Pick Up Peptide Drug Firm KAI Pharmaceuticals for $315M". GEN - Genetic Engineering and Biotechnology News. 10 April 2012.
"Amgen Buys deCODE Genetics for $415M". GEN - Genetic Engineering and Biotechnology News. 10 December 2012.
"GEN - News Highlights:Celimmune Licenses Amgen's AMG 714 for Celiac Disease". GEN.
"For Up to $1.55B, Amgen Acquires Dezima Pharma". GEN. 16 September 2015.
"Amgen, Xencor to Partner on Cancer Immunotherapy, Inflammation Drugs". GEN. 16 September 2015.
"Amgen Buys Rights to Myeloma BiTE Immunotherapy from Boehringer Ingelheim - GEN News Highlights - GEN". September 2016.
Philippidis, Alex (6 January 2022). "Amgen, Generate Launch Up-to-$1.9B Protein Therapeutics Collaboration". GEN - Genetic Engineering and Biotechnology News. Retrieved 23 September 2022.
Sterling, John (11 March 2022). "Amgen Breaks Ground on NC Biomanufacturing Facility". GEN - Genetic Engineering and Biotechnology News. Retrieved 23 September 2022.
Philippidis, Alex (5 August 2022). "Amgen to Acquire ChemoCentryx for $3.7B, Bolstering Autoimmune Portfolio". GEN - Genetic Engineering and Biotechnology News. Retrieved 23 September 2022.

globalhealthprogress.org

"Explore Our Collaborations". Global Health Progress. 2022. Archived from the original on 2022-04-03. Retrieved 2022-08-04.

healio.com

"FDA approves Avsola, fourth Remicade biosimilar". www.healio.com. 6 Dec 2019. Retrieved 11 August 2022.

healthsteward.ca

"Members". Health Products Stewardship Association. 2022. Archived from the original on 2022-04-27. Retrieved 2022-08-04.

hematology.org

"Corporate Support". American Society of Hematology. 2022. Archived from the original on 2022-06-10. Retrieved 2022-08-02.

huffingtonpost.com

"Jon Entine: New York Times Mum After Congressional Budget Office Rebukes Bungled Amgen/Medicare Investigation". Huffington Post. 26 February 2013.

ias.edu

Simonyi, Charles; Dijkgraaf, Robbert (2013). "Report for the Academic Year 2012-2013" (PDF). Institute for Advanced Study. Archived (PDF) from the original on 2022-08-02. Retrieved 2022-08-02.

ifpma.org

"Companies". IFPMA. Archived from the original on 2022-07-01. Retrieved 2022-08-04.

inc.com

"Small Company Initial Public Offerings: June 1983". Inc.com. 1 September 1983. Retrieved 10 August 2022.

innovativemedicines.ca

"Member Companies". Innovative Medicines Canada. 2021. Archived from the original on 2022-05-31. Retrieved 2022-08-04.

irishtimes.com

"Amgen to buy Pfizer plant". The Irish Times. 11 March 2011. Retrieved 10 August 2022.

lapromisefund.org

"Amgen Biotech Experience (ABE-LA)". LA Promise Fund. 2022-02-23. Archived from the original on 2022-08-06. Retrieved 2022-08-06.

latimes.com

Bate, James (2 June 1989). "Biotech Detective Scores Coup : Amgen scientist spent years searching for the key to producing EPO". Los Angeles Times. Retrieved 10 August 2022.
Murphy, Barbara (20 May 1997). "Souza to Run Research at Biotech King Amgen". Los Angeles Times. Retrieved 10 August 2022.
"Gordon M. Binder, chief executive of Amgen..." Los Angeles Times. 17 October 1995. Retrieved 10 August 2022.
Apodaca, Patrice (1993-08-17). "Amgen to Open Puerto Rico Plant Despite Tax Credit Cut : Biotechnology: Analysts say the benefit reduction does not alter expectations of strong long-term growth for the Thousand Oaks giant". Los Angeles Times. Retrieved 2024-05-29.
Nathans, Aaron (16 September 1994). "Amgen, Phone Entrepreneur Win Medal of Technology". Los Angeles Times. Retrieved 10 August 2022.
Gellene, Denise (30 March 2004). "Amgen to Buy Rival Tularik". Los Angeles Times. Retrieved 10 August 2022.
Terhune, Chad (18 December 2012). "Amgen pleads guilty to improper marketing of anemia drug Aranesp". Los Angeles Times. Retrieved 2 February 2013.

lifescienceleader.com

Wright, Rob (27 Aug 2018). "Amgen's Acquisition Of Onyx Pharmaceuticals — Through The Eyes Of Tony Coles". Life Science Leader. Retrieved 11 August 2022.

lifesciencesbc.ca

"Our Sponsors". Life Sciences British Columbia. 2021-01-06. Archived from the original on 2022-04-25. Retrieved 2022-08-04.

marsdd.com

"Amgen—A biotechnology success story | From drug development to the mass market". Archived from the original on 2014-10-24. Retrieved 2016-09-12.

mentoringinibd.com

"Sponsors". Mentoring in IBD. 2022. Archived from the original on 2022-04-19. Retrieved 2022-08-02.

mpacorn.com

"Biotech giant Amgen has big plans for new plant". Moorpark Acorn. 16 February 2018.

nationalgeographic.org

media.nationalgeographic.org

"The Power of Philanthropy" (PDF). National Geographic Society. Archived (PDF) from the original on 2022-05-10. Retrieved 2022-08-04.

nationalhealthcouncil.org

"Our Members". National Health Council. 2022. Archived from the original on 2022-04-06. Retrieved 2022-08-05.

nephrologynews.com

"CBO analysis shows keeping oral drugs out of ESRD bundle could save money | Nephrology News & Issues". Archived from the original on 2013-06-05.

nih.gov

pubmed.ncbi.nlm.nih.gov

Bendall, Linda J.; Bradstock, Kenneth F. (August 2014). "G-CSF: From granulopoietic stimulant to bone marrow stem cell mobilizing agent". Cytokine & Growth Factor Reviews. 25 (4): 355–367. doi:10.1016/j.cytogfr.2014.07.011. PMID 25131807.
Przepiorka, Donna; Ko, Chia-Wen; Deisseroth, Albert; Yancey, Carolyn L.; Candau-Chacon, Reyes; Chiu, Haw-Jyh; Gehrke, Brenda J.; Gomez-Broughton, Candace; Kane, Robert C.; Kirshner, Susan; Mehrotra, Nitin; Ricks, Tiffany K.; Schmiel, Deborah; Song, Pengfei; Zhao, Ping; Zhou, Qing; Farrell, Ann T.; Pazdur, Richard (15 September 2015). "FDA Approval: Blinatumomab". Clinical Cancer Research. 21 (18): 4035–4039. doi:10.1158/1078-0432.CCR-15-0612. ISSN 1557-3265. PMID 26374073. S2CID 207687724. Retrieved 11 August 2022.
Jamali, Faranak; Lemery, Steven; Ayalew, Kassa; Robottom, Suzanne; Robie-Suh, Kathy; Rieves, Dwaine; Pazdur, Richard (July 2009). "Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura". Oncology (Williston Park, N.Y.). 23 (8): 704–709. ISSN 0890-9091. PMID 19711585. Retrieved 10 August 2022.
Giusti, Ruthann M.; Shastri, Kaushikkumar A.; Cohen, Martin H.; Keegan, Patricia; Pazdur, Richard (May 2007). "FDA drug approval summary: panitumumab (Vectibix)". The Oncologist. 12 (5): 577–583. doi:10.1634/theoncologist.12-5-577. ISSN 1083-7159. PMID 17522246. S2CID 9376408. Retrieved 10 August 2022.
Hemmelgarn, Brenda R.; Clement, Fiona; Manns, Braden J.; Klarenbach, Scott; James, Matthew T.; Ravani, Pietro; Pannu, Neesh; Ahmed, Sofia B.; MacRae, Jennifer; Scott-Douglas, Nairne; Jindal, Kailash (2009-10-19). "Overview of the Alberta Kidney Disease Network". BMC Nephrology. 10 (1): 30. doi:10.1186/1471-2369-10-30. ISSN 1471-2369. PMC 2770500. PMID 19840369.

ncbi.nlm.nih.gov

Hemmelgarn, Brenda R.; Clement, Fiona; Manns, Braden J.; Klarenbach, Scott; James, Matthew T.; Ravani, Pietro; Pannu, Neesh; Ahmed, Sofia B.; MacRae, Jennifer; Scott-Douglas, Nairne; Jindal, Kailash (2009-10-19). "Overview of the Alberta Kidney Disease Network". BMC Nephrology. 10 (1): 30. doi:10.1186/1471-2369-10-30. ISSN 1471-2369. PMC 2770500. PMID 19840369.

ns-healthcare.com

"Amgen breaks ground on new biomanufacturing facility in Ohio, US". NS Healthcare. 8 November 2021. Retrieved 20 September 2022.

nytimes.com

Pollack, Andrew; Times, Special To the New York (1991-02-22). "An F.D.A. Approval for Amgen". The New York Times. ISSN 0362-4331. Retrieved 2024-05-29.
"Kirin and Amgen Hormone Venture". The New York Times. Reuters. 15 June 1984. Retrieved 10 August 2022.
Pollack, Andrew (17 July 2002). "Amgen Reports Its Takeover Of Immunex". The New York Times. Retrieved 10 August 2022.
Pollack, Andrew (15 December 2005). "Amgen to Buy Abgenix, Getting Complete Control of New Colon Cancer Drug". The New York Times. Retrieved 10 August 2022.
Pollack, Andrew (20 December 2011). "Amgen Plans to Team Up With Watson on Generics". The New York Times. Retrieved 10 August 2022.
Lipton, Eric (19 January 2013). "Fiscal Footnote: Big Senate Gift to Drug Maker". The New York Times. Retrieved 2 February 2013.
Kolata, Gina (27 August 2015). "F.D.A. Approves Repatha, a Second Drug for Cholesterol in a Potent New Class". The New York Times. Retrieved 11 August 2022.
Pollack, Andrew (19 September 2001). "F.D.A. Approves New Version of Amgen Drug". The New York Times. Retrieved 10 August 2022.

oma.org

"Your impact". Ontario Medical Association. 2022. Archived from the original on 2022-08-05. Retrieved 2022-08-05.

onclive.com

Kristi Rosa (January 10, 2022). "Sotorasib Approved in Europe for KRAS G12C–Mutated Advanced NSCLC". www.onclive.com. Retrieved March 4, 2022.

paab.ca

Pharmaceutique, Pharmaceutical Advertising Advisory Board / Conseil Consultatif de Publicité. "PAAB : About". www.paab.ca. Retrieved 2022-08-05.

pacbiztimes.com

Biasotti, Tony (9 April 2022). "In Thousand Oaks, biotech execs discuss industry's 'rising tide,' lament area's lack of housing". Pacific Coast Business Times. Retrieved 19 September 2022.

personalizedmedicinecoalition.org

"Current Members". Personalized Medicine Coalition. 2021. Archived from the original on 2021-08-15. Retrieved 2022-08-05.

pharmaboardroom.com

Spencer, Dina (26 Sep 2019). "5 Top Pharma Manufacturers in Puerto Rico". PharmaBoardroom. Retrieved 10 August 2022.

pharmaceutical-technology.com

"Amgen's New Bio-manufacturing Plant, Rhode Island, US". Pharmaceutical Technology. 10 August 2018. Retrieved 11 August 2022.
Priyan, Vishnu (2021-10-20). "Amgen concludes acquisition of biotech company Teneobio for $2.5bn". Pharmaceutical Technology. Retrieved 2024-09-11.
Priyan, Vishnu (2022-08-05). "Amgen to acquire biopharma firm ChemoCentryx for $3.7bn". Pharmaceutical Technology. Retrieved 2024-09-11.

pharmaphorum.com

Walsh, Robin (27 October 2010). "A history of: Amgen". pharmaphorum.com. Retrieved 10 August 2022.

philanthropynewsdigest.org

"Amgen Foundation awards $3 million to Khan Academy". Philanthropy News Digest. 24 July 2020. Retrieved 20 September 2022.
"Amgen, AT&T, Others Announce Commitments for COVID-19 Response". Philanthropy News Digest. 25 March 2020. Retrieved 20 September 2022.

phrma.org

"About". Pharmaceutical Research and Manufacturers of America. Archived from the original on 2022-08-05. Retrieved 2022-08-05.

pmlive.com

"Amgen appoints CEO Robert Bradway to chair of board". PMLive. 17 December 2012. Retrieved 10 August 2022.
Taylor, Phil (8 February 2017). "Amgen's chronic kidney disease drug Parsabiv cleared in US". PMLive. Retrieved 11 August 2022.
Jeffries, Fleur (28 March 2022). "Amgen shares new Otezla data at American Academy of Dermatology congress 2022". PMLive. Retrieved 11 August 2022.

providencehealthcare.org

annualreport2019.providencehealthcare.org

"Donor List". Providence Health Care. Archived from the original on 2022-02-08. Retrieved 2022-08-05.

pulmonologyadvisor.com

Dembeck, Lauren (18 October 2021). "NAVIGATOR Trial Outcomes for Tezepelumab Use in Severe, Uncontrolled Asthma". Pulmonology Advisor. Retrieved 16 August 2022.

reaganudall.org

Winckler, Susan C.; Woodcock, Janet (2021-07-01). "Annual Report 2020" (PDF). Reagan-Udall Foundation. Archived (PDF) from the original on 2022-07-12. Retrieved 2022-08-05.

reliasmedia.com

"New FDA Approvals". Relias Media. 1 May 2004. Retrieved 10 August 2022.

researchamerica.org

"Member Organizations". Research!America. 2022. Archived from the original on 2022-04-06. Retrieved 2022-08-05.

reuters.com

"Amgen to buy Micromet for $1.2 billion". Reuters. 26 January 2012. Retrieved 10 August 2022.
"BRIEF-Amgen Establishes Wholly-Owned Affiliate In Japan". Reuters. 1 April 2020. Retrieved 11 August 2022.
"Amgen defeats Novartis appeal over arthritis drug Enbrel's patents". Reuters. 1 July 2020. Retrieved 11 August 2022.
"Amgen bets on $1.9-billion Five Prime deal to grow in Asia-Pacific oncology market". Reuters. 4 March 2021.
"Amgen to invest $100 million in SoftBank-backed Neumora". Reuters. 7 October 2021. Retrieved 20 September 2022.
"U.S. FDA approves expanded use of Amgen's psoriasis drug". Reuters. 20 December 2021. Retrieved 20 September 2022.
Mishra, Manas; Satija, Bhanvi (12 December 2022). "Amgen dives deeper into rare disease drugs with $27.8 BLN Horizon deal". Reuters.
"Amgen completes $27.8 billion Horizon deal". Reuters. 6 October 2023.
Erman, Michael; Mishra, Manas (26 August 2019). "Amgen to buy Celgene psoriasis drug Otezla for $13.4 billion". Reuters. Retrieved 23 September 2022.
Heavey, Susan (22 August 2008). "U.S. FDA approves Amgen's blood platelet booster". Reuters. Retrieved 10 August 2022.
Beasley, Deena (30 November 2020). "COVID R&D Alliance launches trial of Amgen, UCB, Takeda drugs". Reuters. Retrieved 16 August 2022.

uk.reuters.com

"Amgen to buy Copenhagen-based Nuevolution for $167 million". Reuters. 22 May 2019. Archived from the original on May 22, 2019 – via uk.reuters.com.
"Amgen to buy Celgene psoriasis drug Otezla for $13.4 billion". Reuters. 26 August 2019. Archived from the original on August 26, 2019.

rheum.ca

"Corporate Sponsors - CRA". Canadian Rheumatology Association. 2017-11-18. Archived from the original on 2022-03-01. Retrieved 2022-08-02.

seattletimes.com

archive.seattletimes.com

Timmerman, Luke (13 May 2002). "Shrewd science: Biotech giant Amgen's success reflects its savvy corporate style". The Seattle Times. Retrieved 10 August 2022.

sec.gov

"US SEC: 2023 Form 10-K Amgen Inc". U.S. Securities and Exchange Commission. February 14, 2024.

secdatabase.com

edgar.secdatabase.com

"Amgen, Form 10-K405, Filing Date Mar 7, 2000". secdatabase.com. Retrieved Jan 8, 2013.
"Amgen, Form 8-K, Current Report, Filing Date May 24, 2012". secdatabase.com. Retrieved Jan 8, 2013.

semanticscholar.org

api.semanticscholar.org

Przepiorka, Donna; Ko, Chia-Wen; Deisseroth, Albert; Yancey, Carolyn L.; Candau-Chacon, Reyes; Chiu, Haw-Jyh; Gehrke, Brenda J.; Gomez-Broughton, Candace; Kane, Robert C.; Kirshner, Susan; Mehrotra, Nitin; Ricks, Tiffany K.; Schmiel, Deborah; Song, Pengfei; Zhao, Ping; Zhou, Qing; Farrell, Ann T.; Pazdur, Richard (15 September 2015). "FDA Approval: Blinatumomab". Clinical Cancer Research. 21 (18): 4035–4039. doi:10.1158/1078-0432.CCR-15-0612. ISSN 1557-3265. PMID 26374073. S2CID 207687724. Retrieved 11 August 2022.
Giusti, Ruthann M.; Shastri, Kaushikkumar A.; Cohen, Martin H.; Keegan, Patricia; Pazdur, Richard (May 2007). "FDA drug approval summary: panitumumab (Vectibix)". The Oncologist. 12 (5): 577–583. doi:10.1634/theoncologist.12-5-577. ISSN 1083-7159. PMID 17522246. S2CID 9376408. Retrieved 10 August 2022.

sfvbj.com

Pequeño IV, Antonio (23 February 2022). "Amgen Issues 'Green Bond'". San Fernando Valley Business Journal. Retrieved 23 September 2022.

shnfoundation.ca

"Our Donors". Scarborough Health Network Foundation. 2021. Archived from the original on 2022-08-05. Retrieved 2022-08-05.

sickkidsfoundation.com

web.sickkidsfoundation.com

"2020-21 SickKids Annual Report". SickKids Foundation. 2021. Archived from the original on 2022-06-20. Retrieved 2022-08-05.

sinaihealthannualreport.ca

"Donor List - Cumulative". Sinai Health Annual Report. 2021-03-31. Archived from the original on 2022-08-06. Retrieved 2022-08-06.

sobi.com

"Stemgen® (ancestim)". sobi.com. Archived from the original on 2013-12-30. Retrieved 2013-12-30.

statnews.com

"Amgen acquires stake in BeiGene to grow cancer drug business to China". 31 October 2019.
Ross, Casey (10 November 2020). "Drug companies deliver a vote of confidence in adaptive trial for Covid-19". STAT. Retrieved 16 August 2022.

strengthenfda.org

"List of Members". Alliance for a Stronger FDA. 2022-03-04. Archived from the original on 2022-07-08. Retrieved 2022-08-02.

sunnybrook.ca

"Our donors - Your Impact". Sunnybrook Foundation. 2022. Archived from the original on 2022-08-06. Retrieved 2022-08-06.

targetedonc.com

Lisa Astor (September 9, 2019). "FDA Grants AMG 510 Fast Track Designation for KRAS G12C+ NSCLC". targetedonc.com. Retrieved November 16, 2019.

thecrimson.com

Kahn, Natalie L.; Wang, Andy Z. (8 April 2020). "Harvard's LabXChange Provides Platform for Remote Scientific Learning During Pandemic | News | The Harvard Crimson". The Harvard Crimson. Retrieved 11 August 2022.

thepharmaletter.com

"Amgen buys remaining 79% of Tularik for $1.3B to boost R&D pipeline". The Pharma Letter. 4 April 2004. Retrieved 10 August 2022.
"Evenity gets first ever approval, in Japan". The Pharma Letter. 9 January 2019. Retrieved 11 August 2022.
"FDA approves Amgen's new-generation filgrastim product, Neulasta". www.thepharmaletter.com. 2 Nov 2002. Retrieved 10 August 2022.

thepmcf.ca

Fukakusa, Janice; Yamashita, Miyo. "2021 Annual Report" (PDF). Princess Margaret Cancer Centre. Archived (PDF) from the original on 2021-11-20. Retrieved 2022-08-05.

thestreet.com

Ward, Nicholas (21 April 2019). "Amgen: This Beaten Down Blue Chip Is Priced To Own". TheStreet. Retrieved 10 August 2022.

toaks.org

"Annual Comprehensive Financial Report". City of Thousand Oaks, California. 30 June 2021. p. 156. Retrieved 19 September 2022.

uhnfoundation.ca

Hanson, Tennys; Kothari, Raj. "2020/21 Report to Our Donors". UHN Foundation. Archived from the original on 2022-05-07. Retrieved 2022-08-06.

urban.org

Wartell, Sarah Rosen. "2020 Annual Report" (PDF). Urban Institute. Archived (PDF) from the original on 2022-06-30. Retrieved 2022-08-05.

usatoday.com

Molina, Brett (30 July 2020). "Q&A: Khan Academy CEO Sal Khan on the new school year and virtual learning". USA Today. Retrieved 20 September 2022.

utoronto.ca

boundless.utoronto.ca

"Donor Listing". University of Toronto. Archived from the original on 2021-04-23. Retrieved 2022-08-06.

vcstar.com

D'Angelo, Alexa (29 October 2017). "Amgen Foundation awards Khan Academy $3 million to support development of biology". Ventura County Star. Retrieved 11 August 2022.

ventureburn.com

"Amgen forges ahead with generative AI to expedite advanced therapies". Ventureburn. 2023-12-01. Retrieved 2023-12-07.

washingtonpost.com

"Amgen and its erythropoietin drugs". The Washington Post. 19 July 2012. Retrieved 20 September 2022.

web.archive.org

"Amgen—A biotechnology success story | From drug development to the mass market". Archived from the original on 2014-10-24. Retrieved 2016-09-12.
"CBO analysis shows keeping oral drugs out of ESRD bundle could save money | Nephrology News & Issues". Archived from the original on 2013-06-05.
"Amgen to buy Copenhagen-based Nuevolution for $167 million". Reuters. 22 May 2019. Archived from the original on May 22, 2019 – via uk.reuters.com.
"Amgen to buy Celgene psoriasis drug Otezla for $13.4 billion". Reuters. 26 August 2019. Archived from the original on August 26, 2019.
"CDC Foundation Active Programs October 1, 2020 – September 30, 2021". CDC Foundation. 2021-12-09. Archived from the original on 2022-01-15. Retrieved 2022-08-06.
Amgen press office. Biovitrum Closes Product Acquisition Deal with Amgen Archived July 3, 2012, at the Wayback Machine
"Stemgen® (ancestim)". sobi.com. Archived from the original on 2013-12-30. Retrieved 2013-12-30.
"Amgen's Sustainability Report for 2020Q4" (PDF). Archived from the original (PDF) on July 17, 2021. Alt URL
Simonyi, Charles; Dijkgraaf, Robbert (2013). "Report for the Academic Year 2012-2013" (PDF). Institute for Advanced Study. Archived (PDF) from the original on 2022-08-02. Retrieved 2022-08-02.
"Amgen Biotech Experience (ABE-LA)". LA Promise Fund. 2022-02-23. Archived from the original on 2022-08-06. Retrieved 2022-08-06.
"Honor Roll of Donors" (PDF). University of Washington; Amazon Web Services. 2020. Archived (PDF) from the original on 2022-06-10. Retrieved 2022-08-05.
BUKSA Strategic Conference Services (2021). "Virtual Series Sponsor Profile: Amgen". Alberta Kidney Days Virtual Series. Archived from the original on 2022-08-02. Retrieved 2022-08-02.
"Compassion in kidney care: from patients to providers" (PDF). BC Renal Agency. 2013. Archived (PDF) from the original on 2022-01-08. Retrieved 2022-08-02.
"The 8th Princess Margaret Hospital Conference: Developments in Cancer Management". FDocuments India. 2020-07-17. Archived from the original on 2022-06-20. Retrieved 2022-08-05.
"Recognizing your contribution". Kingston University Hospital Foundation. 2019-12-31. Archived from the original on 2022-08-03. Retrieved 2022-08-04.
Fukakusa, Janice; Yamashita, Miyo. "2021 Annual Report" (PDF). Princess Margaret Cancer Centre. Archived (PDF) from the original on 2021-11-20. Retrieved 2022-08-05.
"Our Donors". Scarborough Health Network Foundation. 2021. Archived from the original on 2022-08-05. Retrieved 2022-08-05.
"2020-21 SickKids Annual Report". SickKids Foundation. 2021. Archived from the original on 2022-06-20. Retrieved 2022-08-05.
"Donor List - Cumulative". Sinai Health Annual Report. 2021-03-31. Archived from the original on 2022-08-06. Retrieved 2022-08-06.
"St. Michael's Foundation 2020/21 Annual Report". FlippingBook. 2021. Archived from the original on 2022-08-05. Retrieved 2022-08-05.
"Our donors - Your Impact". Sunnybrook Foundation. 2022. Archived from the original on 2022-08-06. Retrieved 2022-08-06.
Hanson, Tennys; Kothari, Raj. "2020/21 Report to Our Donors". UHN Foundation. Archived from the original on 2022-05-07. Retrieved 2022-08-06.
"Donor Listings". Women's College Hospital Foundation. Archived from the original on 2022-08-05. Retrieved 2022-08-05.
"The Power of Philanthropy" (PDF). National Geographic Society. Archived (PDF) from the original on 2022-05-10. Retrieved 2022-08-04.
"Why sponsor the EURObservational Registry Programme". European Society of Cardiology. 2022. Archived from the original on 2022-06-15. Retrieved 2022-08-03.
"AGM 2010: The Many Faces of Medical Women" (PDF). Federation of Medical Women in Canada. 2010. Archived (PDF) from the original on 2022-03-06. Retrieved 2022-08-03.
"How We're Funded Advocacy & Support". Alliance for Aging Research. 2022. Archived from the original on 2022-07-15. Retrieved 2022-08-02.
"Member Listings". BIOTECanada. 2021-12-23. Archived from the original on 2022-08-02. Retrieved 2022-08-02.
Grumet, Jason (2016). "Dialogue Issue III: The Annual Report Issue 2015-2016" (PDF). Bipartisan Policy Center. Archived (PDF) from the original on 2022-07-07. Retrieved 2022-08-02.
"CDC Foundation Active Programs". CDC Foundation. 2021-12-09. Archived from the original on 2022-01-15. Retrieved 2022-08-02.
"Industry Network". CCRM. 2019-04-10. Archived from the original on 2022-08-02. Retrieved 2022-08-02.
"Membership". European Federation of Pharmaceutical Industries and Associations. 2022. Archived from the original on 2022-07-01. Retrieved 2022-08-02.
"2020 Donors". FNIH 2020 Annual Report. Archived from the original on 2022-03-16. Retrieved 2022-08-03.
"Explore Our Collaborations". Global Health Progress. 2022. Archived from the original on 2022-04-03. Retrieved 2022-08-04.
"Member Companies". Innovative Medicines Canada. 2021. Archived from the original on 2022-05-31. Retrieved 2022-08-04.
"Companies". IFPMA. Archived from the original on 2022-07-01. Retrieved 2022-08-04.
Higgins, Connie (2020-04-28). "Amgen Foundation commits $2M to Ventura and Los Angeles Counties COVID-19 response" (PDF). Amgen. Archived (PDF) from the original on 2022-07-06. Retrieved 2022-08-04.
"Our Members". National Health Council. 2022. Archived from the original on 2022-04-06. Retrieved 2022-08-05.
"Current Members". Personalized Medicine Coalition. 2021. Archived from the original on 2021-08-15. Retrieved 2022-08-05.
"About". Pharmaceutical Research and Manufacturers of America. Archived from the original on 2022-08-05. Retrieved 2022-08-05.
Winckler, Susan C.; Woodcock, Janet (2021-07-01). "Annual Report 2020" (PDF). Reagan-Udall Foundation. Archived (PDF) from the original on 2022-07-12. Retrieved 2022-08-05.
"Corporate Partners". CAR - Canadian Association of Radiologists. 2022. Archived from the original on 2022-07-19. Retrieved 2022-08-02.
"Our Partnerships". Colorectal Cancer Canada. 2021. Archived from the original on 2022-05-16. Retrieved 2022-08-02.
"Your impact". Ontario Medical Association. 2022. Archived from the original on 2022-08-05. Retrieved 2022-08-05.
"Funding Partners". Can-SOLVE CKD Network. 2022. Archived from the original on 2022-08-02. Retrieved 2022-08-02.
Wartell, Sarah Rosen. "2020 Annual Report" (PDF). Urban Institute. Archived (PDF) from the original on 2022-06-30. Retrieved 2022-08-05.
"Fortune 500 company by revenue 2018 cial". www.fortune.com. Archived from the original on 2020-03-29. Retrieved 2019-03-18.

womenscollegehospitalfoundation.com

"Donor Listings". Women's College Hospital Foundation. Archived from the original on 2022-08-05. Retrieved 2022-08-05.

worldcat.org

search.worldcat.org

Pollack, Andrew; Times, Special To the New York (1991-02-22). "An F.D.A. Approval for Amgen". The New York Times. ISSN 0362-4331. Retrieved 2024-05-29.
Przepiorka, Donna; Ko, Chia-Wen; Deisseroth, Albert; Yancey, Carolyn L.; Candau-Chacon, Reyes; Chiu, Haw-Jyh; Gehrke, Brenda J.; Gomez-Broughton, Candace; Kane, Robert C.; Kirshner, Susan; Mehrotra, Nitin; Ricks, Tiffany K.; Schmiel, Deborah; Song, Pengfei; Zhao, Ping; Zhou, Qing; Farrell, Ann T.; Pazdur, Richard (15 September 2015). "FDA Approval: Blinatumomab". Clinical Cancer Research. 21 (18): 4035–4039. doi:10.1158/1078-0432.CCR-15-0612. ISSN 1557-3265. PMID 26374073. S2CID 207687724. Retrieved 11 August 2022.
Jamali, Faranak; Lemery, Steven; Ayalew, Kassa; Robottom, Suzanne; Robie-Suh, Kathy; Rieves, Dwaine; Pazdur, Richard (July 2009). "Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura". Oncology (Williston Park, N.Y.). 23 (8): 704–709. ISSN 0890-9091. PMID 19711585. Retrieved 10 August 2022.
Giusti, Ruthann M.; Shastri, Kaushikkumar A.; Cohen, Martin H.; Keegan, Patricia; Pazdur, Richard (May 2007). "FDA drug approval summary: panitumumab (Vectibix)". The Oncologist. 12 (5): 577–583. doi:10.1634/theoncologist.12-5-577. ISSN 1083-7159. PMID 17522246. S2CID 9376408. Retrieved 10 August 2022.
Walker, Joseph (2022-09-12). "New Cancer Drug Beats Chemotherapy in Study". The Wall Street Journal. ISSN 0099-9660. Retrieved 2022-09-12.
Hemmelgarn, Brenda R.; Clement, Fiona; Manns, Braden J.; Klarenbach, Scott; James, Matthew T.; Ravani, Pietro; Pannu, Neesh; Ahmed, Sofia B.; MacRae, Jennifer; Scott-Douglas, Nairne; Jindal, Kailash (2009-10-19). "Overview of the Alberta Kidney Disease Network". BMC Nephrology. 10 (1): 30. doi:10.1186/1471-2369-10-30. ISSN 1471-2369. PMC 2770500. PMID 19840369.

wraltechwire.com

Talhelm, Matt (7 March 2022). "Amgen to offer workers an average salary of $119,510 at new facility". WRAL TechWire. Retrieved 20 September 2022.
Parker, Jason (7 March 2022). "Amgen expects new Holly Springs plant to be 'a permanent home'". WRAL TechWire. Retrieved 11 July 2023.

wsj.com

Walker, Joseph (4 August 2022). "Amgen to Buy ChemoCentryx for $3.7 Billion". The Wall Street Journal. Archived from the original on 4 August 2022.
Walker, Joseph (2022-09-12). "New Cancer Drug Beats Chemotherapy in Study". The Wall Street Journal. ISSN 0099-9660. Retrieved 2022-09-12.

xconomy.com

Timmerman, Luke (24 January 2011). "Xconomy: Amgen to Acquire BioVex for Up To $1B, to Obtain Cancer-Killing Virus Therapy". Xconomy. Retrieved 10 August 2022.

yahoo.com

finance.yahoo.com

"Biotech Stock Roundup: GILD's Veklury Approved, NVAX Provides Vaccine Update & More". Yahoo Finance. 28 Oct 2020. Retrieved 16 August 2022.